PSLNR, an androgen-receptor prostate-specific lncRNA, is involved in prostate cancer progression Aug. 1, 2019
OXPHOS-dependent population of poor outcome AML can be targeted with the ERBB2 inhibitor mubritinib Aug. 1, 2019
Zinc finger RNA binding protein found to be potent oncogene in colorectal and liver cancers Aug. 1, 2019
Development of a new class of indazole-based MRA by modern CH functionalization chemistry Aug. 1, 2019
Novel bis-indole-derived NR4A1 antagonists inhibit breast cancer cell growth in vitro and in vivo Aug. 1, 2019
Translate Bio reports interim data from phase I/II trial of MRT-5005 in cystic fibrosis July 31, 2019
Aravive reports antitumor activity in phase Ib trial of AVB-500 in platinum-resistant ovarian cancer July 31, 2019
RSS